A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors
Clinical trial NCT02501096 · COMPLETED
Trial details
- NCT number
- NCT02501096
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-22
- Primary completion
- 2020-08-18
- Enrollment
- 357
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.